We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Magnetic Nanoparticles Used to Extract Cancer Cells

By Biotechdaily staff writers
Posted on 28 Jul 2008
A recent paper described a novel method for treating cancer by attaching magnetic nanoparticles to the cancer cells and using a strong magnet to remove them from the body.

Investigators at the Georgia Institute of Technology (Atlanta, USA) mated cancer cell-specific peptides with magnetic cobalt spinel ferrite nanoparticles. In this study, they employed peptide ligands directed at EphA2 receptors on mouse ovarian cancer cells. By using peptide ligands, the investigators hoped to minimize interaction between the nanoparticles and components of the animal's immune system.

Results published in the July 9, 2008, online edition of the Journal of the American Chemical Society revealed that the peptide-coated nanoparticles allowed cell capture from a flow stream in vitro and from the peritoneal cavity of mice with ovarian cancer.

"We have been able to use magnetic nanoparticles to capture free-floating cancer cells and then take them out of the body,” said contributing author Dr. John McDonald, professor of biology at the Georgia Institute of Technology. "This technology may be of special importance in the treatment of ovarian cancer where the malignancy is typically spread by free-floating cancer cells released from the primary tumor into the abdominal cavity.”


Related Links:
Georgia Institute of Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
28 Jul 2008  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
28 Jul 2008  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
28 Jul 2008  |   BioResearch